These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35520131)

  • 1. Discovery of Cobimetinib as a novel A-FABP inhibitor using machine learning and molecular docking-based virtual screening.
    Yang S; Li S; Chang J
    RSC Adv; 2022 Apr; 12(21):13500-13510. PubMed ID: 35520131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases.
    Furuhashi M
    J Atheroscler Thromb; 2019 Mar; 26(3):216-232. PubMed ID: 30726793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The discovery of novel and selective fatty acid binding protein 4 inhibitors by virtual screening and biological evaluation.
    Zhou Y; Nie T; Zhang Y; Song M; Li K; Ding M; Ding K; Wu D; Xu Y
    Bioorg Med Chem; 2016 Sep; 24(18):4310-4317. PubMed ID: 27460668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A-FABP in Metabolic Diseases and the Therapeutic Implications: An Update.
    Li HL; Wu X; Xu A; Hoo RL
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SAR studies on truxillic acid mono esters as a new class of antinociceptive agents targeting fatty acid binding proteins.
    Yan S; Elmes MW; Tong S; Hu K; Awwa M; Teng GYH; Jing Y; Freitag M; Gan Q; Clement T; Wei L; Sweeney JM; Joseph OM; Che J; Carbonetti GS; Wang L; Bogdan DM; Falcone J; Smietalo N; Zhou Y; Ralph B; Hsu HC; Li H; Rizzo RC; Deutsch DG; Kaczocha M; Ojima I
    Eur J Med Chem; 2018 Jun; 154():233-252. PubMed ID: 29803996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipocyte fatty acid-binding protein exacerbates cerebral ischaemia injury by disrupting the blood-brain barrier.
    Liao B; Geng L; Zhang F; Shu L; Wei L; Yeung PKK; Lam KSL; Chung SK; Chang J; Vanhoutte PM; Xu A; Wang K; Hoo RLC
    Eur Heart J; 2020 Sep; 41(33):3169-3180. PubMed ID: 32350521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty acid binding protein (FABP) inhibitors: a patent review (2012-2015).
    Wang YT; Liu CH; Zhu HL
    Expert Opin Ther Pat; 2016 Jul; 26(7):767-76. PubMed ID: 27109571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mAb against adipocyte fatty acid-binding protein 2E4 attenuates the inflammation in the mouse model of high-fat diet-induced obesity via toll-like receptor 4 pathway.
    Miao X; Wang Y; Wang W; Lv X; Wang M; Yin H
    Mol Cell Endocrinol; 2015 Mar; 403():1-9. PubMed ID: 25596549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. An update from 2017 to early 2022.
    Floresta G; Patamia V; Zagni C; Rescifina A
    Eur J Med Chem; 2022 Oct; 240():114604. PubMed ID: 35849941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of VEGFR2 inhibitors by integrating naïve Bayesian classification, molecular docking and drug screening approaches.
    Kang D; Pang X; Lian W; Xu L; Wang J; Jia H; Zhang B; Liu AL; Du GH
    RSC Adv; 2018 Jan; 8(10):5286-5297. PubMed ID: 35542432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational repurposing approach for targeting the critical spike mutations in B.1.617.2 (delta), AY.1 (delta plus) and C.37 (lambda) SARS-CoV-2 variants using exhaustive structure-based virtual screening, molecular dynamic simulations and MM-PBSA methods.
    Ebrahimi M; Karami L; Alijanianzadeh M
    Comput Biol Med; 2022 Aug; 147():105709. PubMed ID: 35728285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice.
    Hoo RL; Lee IP; Zhou M; Wong JY; Hui X; Xu A; Lam KS
    J Hepatol; 2013 Feb; 58(2):358-64. PubMed ID: 23108115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virtual screening approach to identifying influenza virus neuraminidase inhibitors using molecular docking combined with machine-learning-based scoring function.
    Zhang L; Ai HX; Li SM; Qi MY; Zhao J; Zhao Q; Liu HS
    Oncotarget; 2017 Oct; 8(47):83142-83154. PubMed ID: 29137330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening.
    Chtita S; Belhassan A; Aouidate A; Belaidi S; Bouachrine M; Lakhlifi T
    Comb Chem High Throughput Screen; 2021; 24(3):441-454. PubMed ID: 32748740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined deep learning and molecular docking simulations approach identifies potentially effective FDA approved drugs for repurposing against SARS-CoV-2.
    Anwaar MU; Adnan F; Abro A; Khan RA; Rehman AU; Osama M; Rainville C; Kumar S; Sterner DE; Javed S; Jamal SB; Baig A; Shabbir MR; Ahsan W; Butt TR; Assir MZ
    Comput Biol Med; 2022 Feb; 141():105049. PubMed ID: 34823857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting fatty acid binding protein (FABP) anandamide transporters - a novel strategy for development of anti-inflammatory and anti-nociceptive drugs.
    Berger WT; Ralph BP; Kaczocha M; Sun J; Balius TE; Rizzo RC; Haj-Dahmane S; Ojima I; Deutsch DG
    PLoS One; 2012; 7(12):e50968. PubMed ID: 23236415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipocyte Fatty Acid Binding Protein Potentiates Toxic Lipids-Induced Endoplasmic Reticulum Stress in Macrophages via Inhibition of Janus Kinase 2-dependent Autophagy.
    Hoo RL; Shu L; Cheng KK; Wu X; Liao B; Wu D; Zhou Z; Xu A
    Sci Rep; 2017 Jan; 7():40657. PubMed ID: 28094778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases.
    Furuhashi M; Saitoh S; Shimamoto K; Miura T
    Clin Med Insights Cardiol; 2014; 8(Suppl 3):23-33. PubMed ID: 25674026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herbalog: A tool for target-based identification of herbal drug efficacy through molecular docking.
    Wang Y; Hu JS; Lin HQ; Ip TM; Wan DC
    Phytomedicine; 2016 Nov; 23(12):1469-1474. PubMed ID: 27765367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.